Mary Clare Maninang-ocampo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1033 Turnpike Ave Ste 200, Clearfield, PA 16830 Phone: 814-768-7618 Fax: 814-768-7508 |
Sherri Sortor-thompson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1033 Turnpike Ave, Suite 200, Clearfield, PA 16830 Phone: 814-768-7618 Fax: 814-768-7508 |
News Archive
Obese women have an increased risk of hip fracture earlier than others, already well before the age of 70, a new study from the University of Eastern Finland shows. The study followed 12,715 women for a period of 25 years. The new findings from the Osteoporosis Risk Factor and Prevention (OSTPRE) study were published in Osteoporosis International.
"It has been a banner year for media attention, political will and global resources on family planning and women's and girls' rights and empowerment," Ward Cates, president emeritus of FHI 360; Laneta Dorflinger, a scientist with FHI 360; and Kirsten Vogelsong, a senior program officer with the family planning division of the Bill & Melinda Gates Foundation, write in the Huffington Post "Global Motherhood" blog, noting the London Summit on Family Planning, World Contraception Day, and the inaugural International Day of the Girl Child.
Medtronic, Inc. today announced the receipt of CE Mark (Conformité Européenne) and launch of the CapSure Sense MRI SureScan® pacing leads, which are approved for use during Magnetic Resonance Imaging (MRI). Medtronic introduced the first MR-Conditional pacemaker system in the world in 2008 and in the U.S. in 2011.
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.
› Verified 3 days ago